New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe
09.06.2021
New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report released by the EU drugs agency (EMCDDA) (1). Often marketed as ‘designer benzodiazepines’, these substances are sold as ‘legal’ replacements for controlled benzodiazepines and...
